RB Global (NYSE:RBA) Exceeds Q2 CY2026 Expectations

RB Global (NYSE:RBA) reported Q2 CY2026 revenue of $1.32 billion, up 11.1% year on year, exceeding Wall Street estimates by 6.8%. Non-GAAP adjusted EPS was $1.13, up from $1.07, and was roughly in line with consensus. Analysts expect full-year EPS to rise from $4.18 to $4.64.

Original reporting
Published Aug 4, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RB Global (NYSE:RBA) Exceeds Q2 CY2026 Expectations — source image
Decision brief

The 30-second read

$RBANeutralMed
01

Why it matters

Revenue exceeded expectations, but adjusted operating margin profit margin fell sharply year over year, and forward revenue growth expectations were described as decelerating.

02

Market read

This is a single-company earnings-style datapoint: revenue beat with in-line EPS, offset by margin contraction and a decelerating forward revenue outlook.

03

What to watch

The article lacks cash flow, guidance details from management, and segment-level drivers; traders may need those to judge whether margin compression is temporary or structural.

Relevance 7/10Novelty 7/10Timing: after-hours/late-day following Q2 CY2026 results release

Background

RB Global, operator of commercial asset marketplaces, reported Q2 CY2026 results with revenue growth and profitability metrics discussed versus prior year and consensus.

Company-level read

Ticker impact

$RBANeutralMedium confidence
Context

RB Global reported Q2 CY2026 revenue of $1.32B, up 11.1% YoY, exceeding Wall Street estimates by 6.8%, while adjusted EPS of $1.13 was in line.

Expected impact

Near-term upside bias from the revenue beat, tempered by margin contraction and only in-line EPS, likely keeping the stock range-bound unless management commentary changes.

Evidence & confidence

The article provides a concrete beat on revenue versus estimates and a specific profitability deterioration (adjusted operating margin profit margin down 8.7 pts YoY), plus only modest forward growth expectations (analysts see revenue +3.8% over 12 months).

Market effects

Signals business-services demand resilience via revenue growth, but highlights cost pressure through margin compression.

No explicit regional drivers provided in the article.

No explicit global macro or cross-border catalyst beyond company-wide marketplace performance.

Counterpoint

The revenue beat may reflect timing or marketplace cycle effects, while the margin drop suggests underlying unit economics are weakening, limiting sustained multiple expansion.

Key entities

  • RB Global

    NYSE-listed commercial asset marketplace operator reporting Q2 CY2026 revenue and adjusted EPS results.

Related articles

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.

$CPTMedAI 8/10

Camden Property Trust (CPT) Q2 2026 Earnings Call Transcript

Camden Property Trust (CPT) discussed its Q2 2026 earnings call, focusing on exiting its California multifamily portfolio. According to management, it sold the 19-year-old California portfolio for $1.625 billion, with trailing 12-month FFO and AFFO yields of 5.6% and 5.2%. Camden repurchased $694 million of shares and closed $645 million of acquisitions plus $195 million of awarded acquisitions, reaffirming $6.75/share FFO guidance.